151 related articles for article (PubMed ID: 14635205)
1. Malignancy in patients with sickle cell disease.
Schultz WH; Ware RE
Am J Hematol; 2003 Dec; 74(4):249-53. PubMed ID: 14635205
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
Michel M; Habibi A; Godeau B; Bachir D; Lahary A; Galacteros F; Fifi-Mah A; Arfi S
Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923
[TBL] [Abstract][Full Text] [Related]
3. Cancer in Fanconi anemia, 1927-2001.
Alter BP
Cancer; 2003 Jan; 97(2):425-40. PubMed ID: 12518367
[TBL] [Abstract][Full Text] [Related]
4. Secondary neoplasms after radiotherapy for a childhood solid tumor.
Paulino AC; Fowler BZ
Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
[TBL] [Abstract][Full Text] [Related]
5. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
Akar NA; Adekile A
Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.
Chaine B; Neonato MG; Girot R; Aractingi S
Arch Dermatol; 2001 Apr; 137(4):467-70. PubMed ID: 11295927
[TBL] [Abstract][Full Text] [Related]
7. Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes.
de Montalembert M; Brousse V; Elie C; Bernaudin F; Shi J; Landais P;
Haematologica; 2006 Jan; 91(1):125-8. PubMed ID: 16434381
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease.
de Montalembert M; Bachir D; Hulin A; Gimeno L; Mogenet A; Bresson JL; Macquin-Mavier I; Roudot-Thoraval F; Astier A; Galactéros F
Haematologica; 2006 Dec; 91(12):1685-8. PubMed ID: 17145606
[TBL] [Abstract][Full Text] [Related]
9. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
[TBL] [Abstract][Full Text] [Related]
10. Myringotomy and tympanostomy tube placement in children with sickle cell disease.
Tran KD; Koprowska IA; Rao S; Sundaram R; Goldstein NA
Int J Pediatr Otorhinolaryngol; 2004 Oct; 68(10):1301-5. PubMed ID: 15364502
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria in children with sickle cell disease.
Marsenic O; Couloures KG; Wiley JM
Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783
[TBL] [Abstract][Full Text] [Related]
12. [Infections in Senegalese children and adolescents with sickle cell anemia: epidemiological aspects].
Diagne I; Soares GM; Gueye A; Diagne-Gueye NR; Fall L; N'Diaye O; Camara B; Diouf S; Fall M
Dakar Med; 2000; 45(1):55-8. PubMed ID: 14666792
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon.
Njamnshi AK; Mbong EN; Wonkam A; Ongolo-Zogo P; Djientcheu VD; Sunjoh FL; Wiysonge CS; Sztajzel R; Mbanya D; Blackett KN; Dongmo L; Muna WF
J Neurol Sci; 2006 Dec; 250(1-2):79-84. PubMed ID: 16905153
[TBL] [Abstract][Full Text] [Related]
14. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
[TBL] [Abstract][Full Text] [Related]
15. Stroke in Nigerian children with sickle cell disease.
Fatunde OJ; Adamson FG; Ogunseyinde O; Sodeinde O; Familusi JB
Afr J Med Med Sci; 2005 Jun; 34(2):157-60. PubMed ID: 16749340
[TBL] [Abstract][Full Text] [Related]
16. Sickle cell disease: the Lebanese experience.
Inati A; Jradi O; Tarabay H; Moallem H; Rachkidi Y; El Accaoui R; Isma'eel H; Wehbe R; Mfarrej BG; Dabbous I; Taher A
Int J Lab Hematol; 2007 Dec; 29(6):399-408. PubMed ID: 17988293
[TBL] [Abstract][Full Text] [Related]
17. Abnormal rib number in childhood malignancy: implications for the scoliosis surgeon.
Loder RT; Huffman G; Toney E; Wurtz LD; Fallon R
Spine (Phila Pa 1976); 2007 Apr; 32(8):904-10. PubMed ID: 17426637
[TBL] [Abstract][Full Text] [Related]
18. Comparing abstract numerical and visual depictions of risk in survey of parental assessment of risk in sickle cell hydroxyurea treatment.
Patterson CA; Barakat LP; Henderson PK; Nall F; Westin A; Dampier CD; Hsu LL
J Pediatr Hematol Oncol; 2011 Jan; 33(1):4-9. PubMed ID: 21178705
[TBL] [Abstract][Full Text] [Related]
19. Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children.
Miniati D; Gay AN; Parks KV; Naik-Mathuria BJ; Hicks J; Nuchtern JG; Cass DL; Olutoye OO
J Pediatr Surg; 2008 Jul; 43(7):1301-7. PubMed ID: 18639686
[TBL] [Abstract][Full Text] [Related]
20. [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
Mellouli F; Bejaoui M
Arch Pediatr; 2008 Jan; 15(1):24-8. PubMed ID: 18164913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
